innisfree Matte Priming UV Shield Sunscreen

innisfree Matte Priming UV Shield Sunscreen by

Drug Labeling and Warnings

innisfree Matte Priming UV Shield Sunscreen by is a Otc medication manufactured, distributed, or labeled by Innisfree Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

INNISFREE MATTE PRIMING UV SHIELD SUNSCREEN- octisalate, titanium dioxide, and octocrylene lotion lotion 
Innisfree Corporation

----------

innisfree Matte Priming UV Shield Sunscreen

Drug Facts

ACTIVE INGREDIENTS

Octisalate 4.0%

Titanium Dioxide 3.5%

Octocrylene 2.5%

PURPOSE

Sunscreen

USES

  • Helps prevent sunburn
  • If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

WARNINGS

  • For external use only

  • Do not use on damaged or broken skin.

  • When using this product keep out of eyes. Rinse with water to remove.

  • Stop use and ask a doctor if rash occurs.

  • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS

  • Apply liberally 15 minutes before sun exposure
  • Reapply at least every 2 hours.
  • Use a water-resistant sunscreen if swimming or sweating.
  • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including :
    • Limit time in the sun, especially from 10 a.m. - 2 p.m.
  • Wear long-sleeved shirts, pants, hats, and sunglasses.
  • Children under 6 months of age : Ask a doctor.

INACTIVE INGREDIENTS

WATER / AQUA / EAU, DIMETHICONE, CYCLOPENTASILOXANE, BUTYLENE GLYCOL, PROPYLHEPTYL CAPRYLATE, CETYL PEG/PPG-10/1 DIMETHICONE, CAPRYLIC/CAPRIC TRIGLYCERIDE, DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, PROPANEDIOL, POLYSILICONE-11, DISTEARDIMONIUM HECTORITE, VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER, SYNTHETIC FLUORPHLOGOPITE, HDI/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER, 1,2-HEXANEDIOL, MAGNESIUM SULFATE, POLYHYDROXYSTEARIC ACID, METHYL METHACRYLATE CROSSPOLYMER, ALUMINA, FRAGRANCE / PARFUM, STEARIC ACID, CAPRYLYL DIMETHICONE ETHOXY GLUCOSIDE, CAPRYLYL GLYCOL, GLYCERYL CAPRYLATE, SOLIDAGO VIRGAUREA (GOLDENROD) EXTRACT, EUGENIA CARYOPHYLLUS (CLOVE) BUD EXTRACT, ETHYLHEXYLGLYCERIN, DICAPRYLYL CARBONATE, MICA, SILICA, TOCOPHEROL, IRON OXIDES (CI 77491), TRIETHOXYCAPRYLYLSILANE

OTHER INFORMATION

  • Protect the product in this container from excessive heat and direct sun

Questions?

support@us.amorepacific.com

PRINCIPAL DISPLAY PANEL

Innisfree

Gentle Care

for Sensitive Skin

Sunscreen

Braod Spectrum SPF 29

40 mL / 1.35 Fl. Oz.

1

2

INNISFREE MATTE PRIMING UV SHIELD SUNSCREEN 
octisalate, titanium dioxide, and octocrylene lotion lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 71220-083
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE2 g  in 50 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE1.25 g  in 50 mL
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE1.75 g  in 50 mL
Inactive Ingredients
Ingredient NameStrength
GLYCERYL CAPRYLATE (UNII: TM2TZD4G4A)  
PROPYLHEPTYL CAPRYLATE (UNII: 991Z19V2OD)  
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5)  
PROPANEDIOL (UNII: 5965N8W85T)  
SOLIDAGO VIRGAUREA WHOLE (UNII: F45YHM06JE)  
MICA (UNII: V8A1AW0880)  
TOCOPHEROL (UNII: R0ZB2556P8)  
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)  
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (HARD PARTICLE) (UNII: H895X08VNQ)  
WATER (UNII: 059QF0KO0R)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2) (UNII: V2W71V8T0X)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR)  
1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
MAGNESIUM SULFATE, UNSPECIFIED (UNII: DE08037SAB)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER (UNII: WB5K9Y35Y9)  
POLYHYDROXYSTEARIC ACID (2300 MW) (UNII: YXH47AOU0F)  
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER (UNII: EG97988M5Q)  
ALUMINUM OXIDE (UNII: LMI26O6933)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
CLOVE (UNII: K48IKT5321)  
DICAPRYLYL CARBONATE (UNII: 609A3V1SUA)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 71220-083-091 in 1 CARTON06/15/202005/04/2025
150 mL in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02006/15/202005/04/2025
Labeler - Innisfree Corporation (557822425)

Revised: 11/2023
Document Id: 0b52e695-b6ea-1737-e063-6394a90a67e4
Set id: a71bc745-72f4-132e-e053-2995a90a39a8
Version: 3
Effective Time: 20231129
 
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.